DSGN SCHEDULE 13G: SEC filing
Sirenia Capital Management LP and Alex Silverstein
Filed with the SEC on · accession 0000919574-26-005202
DSGN filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +3.1% by the first close after the filing.
Summary of the filing
Sirenia Capital Management LP and Alex Silverstein filed a joint Schedule 13G disclosing a passive ownership position in Design Therapeutics, Inc. The filing includes a joint filing agreement dated August 14, 2026.
Key details
How DSGN stock reacted
Close before
$14.39
Aug 13, 2026
First close after
+3.06%
$14.83
5 trading days
+8.13%
$15.56
Since filing
-29.05%
$10.21
✦ Ask GOAX AI about this filing — what it means for DSGN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DSGN?
Click hereFrequently asked questions
What did DSGN file with the SEC on Aug 14, 2026?
DSGN filed a SCHEDULE 13G (SEC filing). Sirenia Capital Management LP and Alex Silverstein filed a joint Schedule 13G disclosing a passive ownership position in Design Therapeutics, Inc. The filing includes a joint filing agreement dated August 14, 2026.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did DSGN stock react to this filing?
DSGN closed at $14.39 before the filing and $14.83 on Aug 14, 2026 (+3.06%). Five trading days later: $15.56 (+8.13%).
Other DSGN SEC filings
- S-3 · Shelf registrationNov 4, 2026
- 424B5 · Shelf registrationNov 4, 2026
- 10-Q · SEC filingNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 3, 2026
- 8-K · SEC filingAug 3, 2026
- 8-K · Board changeJun 11, 2026
- 8-K · Fda approvalMay 18, 2026
- 10-Q · SEC filingApr 28, 2026
Get alerts when DSGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days